Skip to main navigation Skip to search Skip to main content

sEcad as a Novel Target and Therapy for IGF-1R Expressing Tumors

Project: Research

Project Details

StatusFinished
Effective start/end date03/1/16 → 08/31/18

Funding

  • National Cancer Institute: $144,754.00